psalexa

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
Published Report Code Available Format Pages
 September 2017  LS10753    214

Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation

Place an order

USD 2800
USD 3350
USD 5000
We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. More info X